Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma

This trial is an open-label, multicenter, monotherapy, dose-escalation, phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary anti-tumor activity of NB02 (posseltinib) in patients with relapsed/refractory NHL including FL, MCL and MZL

Participants needed: 9
Trial details
Phase: Phase 1Age: 19-80Biological sex: AllType: InterventionalSponsor: NOBO MedicineUpdated: Jan 30, 2026Locations: 6
Eligibility criteria

Age 19 to 80 years. [+5]

Previous treatment with NB02 (poseltinib). [+6]

Read more
Status: Recruiting

NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL

An Open, Single treatment arm, Multi-center, Prospective, Phase 2 Trial to Evaluate Efficacy and Safety of NB02 (Poseltinib) combined with Rituximab and Lenalidomide as a Salvage Therapy for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Participants needed: 33
Trial details
Phase: Phase 2Age: 19-80Biological sex: AllType: InterventionalSponsor: NOBO MedicineUpdated: Dec 17, 2024Locations: 10
Eligibility criteria

A patient who voluntarily decided to participate and provided written consent af... [+7]

Patients newly diagnosed with primary central nervous system lymphoma (PCNSL). [+14]

Read more